Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer.

Qi Y, Fu X, Xiong Z, Zhang H, Hill SM, Rowan BG, Dong Y.

PLoS One. 2012;7(2):e31539. doi: 10.1371/journal.pone.0031539. Epub 2012 Feb 14.

2.

Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.

Hu H, Li GX, Wang L, Watts J, Combs GF Jr, Lü J.

Clin Cancer Res. 2008 Feb 15;14(4):1150-8. doi: 10.1158/1078-0432.CCR-07-4037.

4.

Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.

Snyder RM, Yu W, Jia L, Sanders BG, Kline K.

Nutr Cancer. 2008;60(3):401-11. doi: 10.1080/01635580701759716.

PMID:
18444175
5.

Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.

Spänkuch B, Heim S, Kurunci-Csacsko E, Lindenau C, Yuan J, Kaufmann M, Strebhardt K.

Cancer Res. 2006 Jun 1;66(11):5836-46.

6.

Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.

Fiskus W, Hembruff SL, Rao R, Sharma P, Balusu R, Venkannagari S, Smith JE, Peth K, Peiper SC, Bhalla KN.

Breast Cancer Res Treat. 2012 Sep;135(2):433-44. doi: 10.1007/s10549-012-2171-9. Epub 2012 Jul 24.

PMID:
22825030
7.

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.

Wang S, Huang J, Lyu H, Cai B, Yang X, Li F, Tan J, Edgerton SM, Thor AD, Lee CK, Liu B.

Breast Cancer Res. 2013;15(5):R101.

8.

A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.

Shi Y, Sun L, Chen G, Zheng D, Li L, Wei W.

Target Oncol. 2015 Dec;10(4):565-73. doi: 10.1007/s11523-015-0364-y. Epub 2015 Apr 29. Erratum in: Target Oncol. 2017 Jan 24;:. Target Oncol. 2017 Apr;12 (2):263.

PMID:
25916999
10.

KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.

Anbalagan M, Carrier L, Glodowski S, Hangauer D, Shan B, Rowan BG.

Breast Cancer Res Treat. 2012 Apr;132(2):391-409. doi: 10.1007/s10549-011-1513-3. Epub 2011 Apr 21.

PMID:
21509526
11.

IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.

Benatar T, Yang W, Amemiya Y, Evdokimova V, Kahn H, Holloway C, Seth A.

Breast Cancer Res Treat. 2012 Jun;133(2):563-73. doi: 10.1007/s10549-011-1816-4. Epub 2011 Oct 14.

PMID:
21997538
12.

STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.

Newman SP, Foster PA, Stengel C, Day JM, Ho YT, Judde JG, Lassalle M, Prevost G, Leese MP, Potter BV, Reed MJ, Purohit A.

Clin Cancer Res. 2008 Jan 15;14(2):597-606. doi: 10.1158/1078-0432.CCR-07-1717.

13.

Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.

Lin YJ, Zhen YS.

Anticancer Drugs. 2009 Jan;20(1):65-72. doi: 10.1097/CAD.0b013e3283182913.

PMID:
19343002
14.

Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells.

Li Z, Carrier L, Rowan BG.

Mol Cancer Ther. 2008 Sep;7(9):3056-63. doi: 10.1158/1535-7163.MCT-07-2142.

15.

MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours.

Khandelwal A, Gediya L, Njar V.

Br J Cancer. 2008 Apr 8;98(7):1234-43. doi: 10.1038/sj.bjc.6604295. Epub 2008 Mar 18.

16.

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.

Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE.

Clin Cancer Res. 2005 Oct 15;11(20):7490-8.

17.

Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.

Al Safarjalani ON, Rais R, Naguib FN, el Kouni MH.

Cancer Chemother Pharmacol. 2012 Jun;69(6):1449-55. doi: 10.1007/s00280-012-1842-x. Epub 2012 Feb 29.

PMID:
22373605
18.
19.

Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.

Choi YH, Yoo YH.

Oncol Rep. 2012 Dec;28(6):2163-9. doi: 10.3892/or.2012.2060. Epub 2012 Sep 26.

PMID:
23023313
20.

The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models.

Michaelson JS, Kelly R, Yang L, Zhang X, Wortham K, Joseph IB.

Cancer Biol Ther. 2012 Jul;13(9):812-21. Epub 2012 Jun 6.

PMID:
22669574

Supplemental Content

Support Center